top of page

Cardiac Disease

Exploring iPSC-based cell therapies for cardiac disease.

  • 2 hours
  • 8,500 US dollars

Service Description

iPSC-derived cardiomyocytes and endothelial cells could potentially be used to replace damaged cells in the heart. But the clinical application of such cell therapies for cardiac disease requires further preclinical and clinical evaluation.

bottom of page